RESEARCH LIBRARY

Journal of Graduate Medical Education: Volume 14, Issue 6, Pages 634-638

This article discusses recent recommendations from the UME-GME Review Committee (UGRC) to address challenges in the UME-GME transition—including complexity, negative impact on well-being, costs, and inequities.

Academic Medicine: Volume 98 - Issue 2 - Pages 180-187

This article describes the work of the Coalition for Physician Accountability’s Undergraduate Medical Education to Graduate Medical Education Review Committee (UGRC) to apply a quality improvement approach and systems thinking to explore the underlying causes of dysfunction in the undergraduate medical education (UME) to graduate medical education (GME) transition.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.